<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Unruptured intracranial aneurysms</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Unruptured intracranial aneurysms</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Unruptured intracranial aneurysms</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert J Singer, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christopher S Ogilvy, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Guy Rordorf, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">José Biller, MD, FACP, FAAN, FAHA</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Janet L Wilterdink, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 11, 2020.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Most subarachnoid hemorrhages (SAHs) are caused by ruptured intracranial saccular (berry) aneurysms [<a href="#rid1">1-5</a>]. The epidemiology and pathogenesis of intracranial aneurysms and the management of unruptured aneurysms are discussed here. The epidemiology, etiology, clinical manifestations, diagnosis, and treatment of SAH, and issues related to screening for aneurysms, are discussed separately. (See  <a class="medical medical_review" href="/d/html/1130.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis"</a> and  <a class="medical medical_review" href="/d/html/1135.html" rel="external">"Screening for intracranial aneurysm"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The prevalence of intracranial saccular aneurysms by radiographic and autopsy series is estimated to be 3.2 percent in a population without comorbidity, a mean age of 50 years, and a 1:1 gender ratio [<a href="#rid1">1,6,7</a>]. Of patients with cerebral aneurysms, 20 to 30 percent have multiple aneurysms [<a href="#rid8">8</a>]. Aneurysmal subarachnoid hemorrhage (SAH) occurs at an estimated rate of 6 to 16 per 100,000 population [<a href="#rid9">9</a>]. In North America, this translates into approximately 30,000 affected persons per year. Thus, most aneurysms, particularly small aneurysms, do not rupture. (See <a class="local">'Risk factors for aneurysm rupture'</a> below.)</p><p>Rupture of an intracranial aneurysm is believed to account for 0.4 to 0.6 percent of all deaths. Approximately 10 percent of patients die prior to reaching the hospital, and only one-third have a "good result" after treatment. (See  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis"</a>.)</p><p>Most intracranial aneurysms (approximately 85 percent) are located in the anterior circulation, predominantly on the circle of Willis. Common sites include the junction of the anterior communicating artery with the anterior cerebral artery, the junction of the posterior communicating artery with the internal carotid artery, and the bifurcation of the middle cerebral artery. Posterior circulation sites often include the top of the basilar artery, the junction of the basilar artery and the superior or anterior inferior cerebellar arteries, and the junction of the vertebral artery and the posterior inferior cerebellar artery [<a href="#rid10">10</a>].</p><p>There is a female preponderance for aneurysms ranging from 54 to 61 percent [<a href="#rid7">7,9</a>]. In populations older than 50 years, the increased prevalence in women may approach a 2:1 ratio or greater.</p><p class="headingAnchor" id="H796071446"><span class="h1">RISK FACTORS FOR ANEURYSM FORMATION</span></p><p class="headingAnchor" id="H5"><span class="h2">Genetic factors</span><span class="headingEndMark"> — </span>The role for genetic factors in the pathogenesis of intracranial aneurysm formation is supported by studies that have found an increased risk in patients with some known hereditary syndromes and by the occurrence of aneurysms in families. A systematic review and meta-analysis confirmed a substantial genetic contribution to the occurrence of intracranial aneurysms that involve multiple pathophysiologic pathways, while noting that large-scale replication studies in a full spectrum of populations are needed with investigation on how specific genetic factors relate to aneurysm size, location, and risk of rupture [<a href="#rid11">11</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hereditary syndromes</strong> – A known hereditary syndrome is often present when aneurysms are diagnosed in more than one family member. Heritable disorders associated with the presence of intracranial aneurysm include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Connective tissue diseases such as Ehlers-Danlos syndrome and pseudoxanthoma elasticum are associated with intracranial aneurysms [<a href="#rid12">12,13</a>], but probably not Marfan syndrome [<a href="#rid14">14</a>]. The mechanism by which connective tissue diseases predispose to aneurysm formation presumably involves an inherent weakness of the arterial wall exposed to the nonlaminar flow pattern of blood, which is then exposed to shear stresses. Aneurysm formation in glucocorticoid-remediable hyperaldosteronism may result in part from congenital hypertension during the early stages of cerebrovascular development [<a href="#rid15">15</a>]. Concurrent hypertension also may contribute in polycystic kidney disease (PKD), although the precise mechanism is unclear. It is uncertain whether patients with these disorders should undergo routine screening for intracranial aneurysm. (See  <a class="medical medical_review" href="/d/html/1135.html" rel="external">"Screening for intracranial aneurysm", section on 'Other hereditary disorders'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Autosomal dominant PKD is associated with a 6.9 times higher risk of intracranial aneurysm [<a href="#rid7">7</a>]. Autosomal recessive PKD may also be a risk factor [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/d/html/1679.html" rel="external">"Autosomal dominant polycystic kidney disease (ADPKD): Extrarenal manifestations"</a>.)</p><p></p><p class="bulletIndent2">The role of aneurysm screening in patients with PKD is discussed separately. (See  <a class="medical medical_review" href="/d/html/1135.html" rel="external">"Screening for intracranial aneurysm", section on 'Autosomal dominant polycystic kidney disease'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Glucocorticoid-remediable aldosteronism (familial aldosteronism type I). (See  <a class="medical medical_review" href="/d/html/122.html" rel="external">"Familial hyperaldosteronism"</a>.)</p><p></p><p class="bulletIndent2">Screening in these patients is described separately. (See  <a class="medical medical_review" href="/d/html/1135.html" rel="external">"Screening for intracranial aneurysm", section on 'Other hereditary disorders'</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Moyamoya syndrome is also associated with an increased frequency of intracranial aneurysms. Although most cases of moyamoya are sporadic, there is probably a genetic susceptibility underlying the disease, and familial occurrence is known to occur. (See  <a class="medical medical_review" href="/d/html/1131.html" rel="external">"Moyamoya disease and moyamoya syndrome: Etiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Familial aneurysms</strong> – Family members of patients with intracranial aneurysms are at increased risk of having an aneurysm, even in the absence of a known hereditary syndrome. In one study, for example, the age-adjusted prevalence of incidental aneurysms in first-degree relatives of patients with an aneurysm was 9 percent, a number significantly higher than the general population [<a href="#rid17">17</a>]. Only a small proportion of these families had an identifiable hereditary syndrome known to be associated with aneurysms. In a second report of patients with mostly sporadic subarachnoid hemorrhage (SAH), intracranial aneurysms were found in 4 percent of first-degree relatives (approximately twice that of the general population) [<a href="#rid18">18</a>]. Other studies have estimated that a family history of aneurysm or SAH confers a 3.6 times greater risk [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1">The mode of inheritance is variable, with autosomal dominant, recessive, and multifactorial transmission evident in different families [<a href="#rid19">19,20</a>]. Familial aneurysms have been linked to multiple chromosomal loci [<a href="#rid11">11,20-26</a>].</p><p></p><p class="bulletIndent1">Familial aneurysms tend to rupture at a smaller size and younger age than sporadic aneurysms [<a href="#rid17">17,27,28</a>]. Siblings often experience rupture in the same decade of life [<a href="#rid27">27</a>]. Aneurysms tend to occur at similar locations within families, suggesting that a specific anatomic vulnerability may be inherited [<a href="#rid29">29</a>].</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Other factors</span><span class="headingEndMark"> — </span>Because intracranial aneurysms are the major etiology of SAH, risk factors for SAH may also be risk factors for intracranial aneurysms. Risk factors for SAH include hypertension, cigarette smoking, and alcohol consumption [<a href="#rid30">30-32</a>]. (See  <a class="medical medical_review" href="/d/html/1130.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis"</a>.)</p><p>Hypercholesterolemia and regular physical exercise appear to decrease the risk of aneurysm formation [<a href="#rid33">33</a>].</p><p>Known and possible risk factors for aneurysm formation include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cigarette smoking</strong> – The importance of cigarette smoking was illustrated in a case-control analysis of 45 men and 70 women with SAH between the ages of 35 and 64 [<a href="#rid34">34</a>]. Cigarette smokers had a significantly increased risk of SAH compared with a control population; the relative risk for men and women was 3.0 and 4.7, respectively, and the risk increased with the number of cigarettes smoked. Those who both smoked and had hypertension had an almost 15-fold increase in risk of SAH compared with normotensive nonsmokers; this additive effect of hypertension and smoking on aneurysm formation has been noticed in other studies as well [<a href="#rid33">33</a>]. In a study of familial intracranial aneurysms, the risk of intracranial aneurysm within affected families was increased by cigarette smoking [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent1">The mechanism by which cigarette smoking predisposes to aneurysm formation may involve decreasing the effectiveness of alpha-1 antitrypsin, an important inhibitor of proteases such as elastase [<a href="#rid10">10</a>]. Support for this hypothesis is derived from studies, which suggest that patients with alpha-1 antitrypsin deficiency are at increased risk of aneurysm formation [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypertension</strong> – The association between hypertension and aneurysm formation and rupture has been controversial, although the balance of evidence suggests that hypertension is a risk factor [<a href="#rid33">33</a>]. One report, for example, compared 113 patients with SAH and angiographically verified aneurysms with 63 patients with SAH but no aneurysm [<a href="#rid35">35</a>]. Blood pressure greater than 160/95 was present in 62 percent of patients with aneurysms compared with 37 percent without. In another study in which over 20,000 Medicare patients were followed, there was an increased prevalence of hypertension in patients with aneurysms compared with a control population (43 versus 35 percent) [<a href="#rid36">36</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Estrogen deficiency</strong> – There is a female preponderance for aneurysms ranging from 54 to 61 percent [<a href="#rid9">9</a>]. The estrogen deficiency of menopause causes a reduction in the collagen content of tissues. (See  <a class="medical medical_review" href="/d/html/7395.html" rel="external">"Clinical manifestations and diagnosis of menopause"</a>.)</p><p></p><p class="bulletIndent1">This collagen wasting may contribute to aneurysm development in postmenopausal women, analogous to the situation in patients with connective tissue diseases. In one case-control study, premenopausal women without a history of smoking or hypertension were at reduced risk of SAH compared with age-matched postmenopausal women (odds ratio 0.24) [<a href="#rid37">37</a>]. Furthermore, the use of estrogen replacement therapy was associated with a reduced risk of SAH in postmenopausal women (odds ratio 0.47). This protective effect of estrogen replacement therapy has been seen in other studies as well [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Coarctation of the aorta</strong> – Patients with coarctation of the aorta are at increased risk for aneurysm formation [<a href="#rid39">39-41</a>]. This may result from secondary hypertension or from shared morphologic or genetic risk factors. (See  <a class="medical medical_review" href="/d/html/5760.html" rel="external">"Clinical manifestations and diagnosis of coarctation of the aorta"</a>.) </p><p></p><p class="headingAnchor" id="H429083121"><span class="h1">PATHOGENESIS</span></p><p class="headingAnchor" id="H796071790"><span class="h2">Aneurysm formation</span><span class="headingEndMark"> — </span>Saccular aneurysms are responsible for most subarachnoid hemorrhages (SAHs), although fusiform and mycotic aneurysms can be identified in selected patients.</p><p class="bulletIndent1"><span class="glyph">●</span>Saccular aneurysms are thin-walled protrusions from the intracranial arteries that are composed of a very thin or absent tunica media, and an absent or severely fragmented internal elastic lamina [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fusiform aneurysms consist of enlargement or dilatation of the entire circumference of the involved vessel that may in part be formed due to atherosclerosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mycotic aneurysms usually result from infected emboli due to infective endocarditis [<a href="#rid43">43</a>].</p><p></p><p>Intracranial saccular aneurysms are acquired lesions, not congenital. The pathogenesis of saccular aneurysm formation is multifactorial [<a href="#rid44">44</a>]. Hemodynamic stress causes excessive wear and tear and breakdown of the internal elastic lamina. Turbulent blood flow produces vibrations that may coincide with the resonant frequency of the vessel wall, resulting in structural fatigue. Patients with hyperdynamic flow patterns as a result of anomalous collateral pathways or other high-flow states are predisposed to accelerated degenerative changes in the vessel wall and subsequent aneurysm development. Hypertension, cigarette smoking, and connective tissue disease probably play a contributory rather than causal role in this process (see <a class="local">'Other factors'</a> above). There is some evidence that inflammation plays a role in the pathogenesis and growth of intracranial aneurysms [<a href="#rid45">45-48</a>].</p><p>In a study that examined 66 saccular aneurysm samples (42 ruptured and 24 unruptured), four histologic types of aneurysm walls were identified that may reflect consecutive stages of degeneration leading to rupture [<a href="#rid49">49</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Endothelialized wall with linearly organized smooth muscle cells (Type A); 7 of 17 (41 percent) ruptured.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thickened wall with disorganized smooth muscle cells (Type B); 11 of 20 (55 percent) ruptured.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypocellular wall with either intimal hyperplasia or organizing luminal thrombosis (Type C); 9 of 14 (64 percent) ruptured.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Extremely thin thrombosis-lined hypocellular wall (Type D); all 15 (100 percent) ruptured.</p><p></p><p>Lack of elastic lamina was a common feature of both ruptured and unruptured aneurysms. Ruptured aneurysm walls were more likely to have complete absence of endothelial lining and evidence of inflammation, characterized by T cell and macrophage infiltration, compared with unruptured walls. Subsequent pathologic studies identified odontogenic bacterial DNA in the walls of both ruptured and unruptured aneurysms, suggesting that infection may play a role in the formation or rupture of saccular aneurysms [<a href="#rid50">50,51</a>].</p><p class="headingAnchor" id="H429083146"><span class="h2">Aneurysm growth and rupture</span><span class="headingEndMark"> — </span>It is believed that most intracranial aneurysms develop over a short period of hours, days, or weeks, attaining a size allowed by the elasticity limits of the aneurysmal wall; at this point, the aneurysm either ruptures or undergoes stabilization and hardening [<a href="#rid44">44,52,53</a>]. Those aneurysms that do not rupture gain significant tensile strength due to compensatory hardening with formation of excessive collagen. Therefore, the likelihood of rupture decreases unless the size of the aneurysm is fairly large at the time of initial stabilization. Aneurysms 1 cm or larger at initial stabilization are considerably more likely to undergo subsequent growth and rupture because wall stress increases with the square of the diameter (Laplace's law). (See <a class="local">'Size'</a> below.)</p><p>This theory of aneurysm growth and rupture is believed to explain the apparent discrepancy between data that show a low rate of rupture for aneurysms 7 to 10 mm and smaller [<a href="#rid52">52,54-56</a>] and the observation that a large percentage of patients that present with SAH appear to have had rupture of aneurysms that were smaller than 10 mm in diameter [<a href="#rid57">57</a>], and a majority appear smaller than 7 mm in diameter [<a href="#rid58">58</a>]. Thus, the critical size for aneurysmal rupture is smaller for aneurysms that rupture soon after formation, as would appear to be true for the vast majority of small aneurysms that rupture [<a href="#rid44">44,53</a>]. This hypothesis is based on data derived from patients with unruptured aneurysms and no history of prior SAH, and may not be applicable to patients who have an unruptured aneurysm and prior SAH from another aneurysm.</p><p class="headingAnchor" id="H796072008"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Most intracranial aneurysms are asymptomatic unless they rupture, and so they are usually found either incidentally or when a patient presents with subarachnoid hemorrhage (SAH). (See  <a class="medical medical_review" href="/d/html/1130.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis"</a>.)</p><p>Some unruptured aneurysms can become symptomatic [<a href="#rid59">59,60</a>]. Symptoms include headache (which may be severe and comparable to the headache of SAH [<a href="#rid59">59</a>]), visual acuity loss, cranial neuropathies (particularly third nerve palsy), pyramidal tract dysfunction, and facial pain; they are felt to be due to the mass effect of the aneurysm. (See  <a class="medical medical_review" href="/d/html/5246.html" rel="external">"Third cranial nerve (oculomotor nerve) palsy in adults"</a>.) </p><p>Ischemia can occur as a result of emboli originating from within an aneurysm.</p><p>Treatment of the aneurysm may lead to resolution of symptoms [<a href="#rid60">60</a>]. (See  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis"</a>.)</p><p class="headingAnchor" id="H796072014"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Most intracranial aneurysms present as subarachnoid hemorrhage (SAH) or are found incidentally or on screening. (See  <a class="medical medical_review" href="/d/html/1135.html" rel="external">"Screening for intracranial aneurysm"</a>.) </p><p>Because symptomatic unruptured aneurysms are unusual, there are few data on the best diagnostic strategy in the presence of symptoms that could be due to an aneurysm. One exception is the clinical setting of a non-pupil sparing third nerve palsy, the evaluation of which is discussed separately. (See  <a class="medical medical_review" href="/d/html/5246.html" rel="external">"Third cranial nerve (oculomotor nerve) palsy in adults", section on 'Evaluation for intracranial aneurysm'</a>.)</p><p>Magnetic resonance angiography (MRA) and computed tomography angiography (CTA) appear to be able to detect aneurysms 5 mm or larger; smaller aneurysms (down to 2 mm) are less reliably detected or may be seen in retrospect when compared with cerebral angiography (<a class="graphic graphic_diagnosticimage graphicRef93978" href="/d/graphic/93978.html" rel="external">image 1</a>) [<a href="#rid61">61-64</a>]. A systematic review of studies of CTA concluded that the sensitivity of CTA ranged from 53 percent for 2 mm aneurysms to 95 percent for 7 mm aneurysms, and that specificity was also higher for larger aneurysms (<a class="graphic graphic_figure graphicRef81565 graphicRef69728" href="/d/graphic/81565.html" rel="external">figure 1A-B</a>) [<a href="#rid64">64</a>]. As technology improves, the sensitivity and specificity of noninvasive imaging is also likely to improve. A 2011 meta-analysis of CTA diagnosis of intracranial aneurysms found that, compared with single-detector CTA, use of multidetector CTA was associated with an overall improved sensitivity and specificity for aneurysm detection (both &gt;97 percent) as well as improved detection of smaller aneurysms ≤4 mm in diameter [<a href="#rid65">65</a>]. Another study examining 307 aneurysm in 246 patients found that three-dimensional time-of-flight MRA with volume rendering at 3.0 Tesla had a sensitivity and specificity of 99 and 97 percent, respectively, that was irrespective of aneurysm size (range &lt;3 to &gt;10 mm) [<a href="#rid66">66</a>].</p><p>Pretest probability should affect the interpretations of CTA results: in the presence of SAH, an aneurysm is likely, and a positive CTA finding of any size can generally be trusted, while a negative result should lead to further testing; in the absence of SAH, a CTA finding of a large aneurysm (&gt;7 mm) can be trusted, but findings of small or medium aneurysms have a higher likelihood of being false positives and may require confirmation, if felt to be clinically important [<a href="#rid64">64</a>].</p><p>Angiography is a more invasive test that is associated with a higher risk of complications, and it should only be performed if there is a high clinical suspicion for an aneurysm despite negative noninvasive studies. Very small aneurysms (below the practical limit of detection of MRA and CTA) can occasionally present with symptoms such as third nerve palsy [<a href="#rid60">60</a>].</p><p class="headingAnchor" id="H13"><span class="h1">RISK FACTORS FOR ANEURYSM RUPTURE</span><span class="headingEndMark"> — </span>Two large prospective studies have reported on the natural history of unruptured intracranial aneurysms, the International Study of Unruptured Intracranial Aneurysms (ISUIA), which prospectively assessed 1692 patients with 2686 unruptured, untreated aneurysms (6544 patient-years) in the United States, Canada, and Europe [<a href="#rid54">54</a>], and the Unruptured Cerebral Aneurysms Study (UCAS), a Japanese cohort that followed 6697 aneurysms in 5720 patients (11,660 aneurysm-years) [<a href="#rid67">67</a>]. Both of these studies noted that aneurysm size and location were associated with the risk of rupture. </p><p>The PHASES score, developed from the pooled analysis of six prospective cohort studies, incorporates age, hypertension, the maximum diameter of the aneurysm, a previous history of subarachnoid hemorrhage (SAH), and the site of the aneurysm as the main predictors of rupture [<a href="#rid68">68</a>] and provides a useful summary for individualization of management decisions [<a href="#rid69">69</a>]. </p><p class="headingAnchor" id="H14"><span class="h2">Size</span><span class="headingEndMark"> — </span>The ISUIA and UCAS confirmed results from previous studies showing that the rates of aneurysmal rupture were lower in smaller aneurysms [<a href="#rid52">52,54-56,67</a>]. The size cutpoint in both studies for defining low risk of rupture was 7 mm [<a href="#rid54">54,67</a>]. With increasing size over 7 mm, the risk of aneurysmal SAH increases correspondingly. In the ISUIA, for anterior circulation aneurysms, five-year rates of rupture for those 7 to 12 mm was 2.6 percent; for those 13 to 24 mm, 14.5 percent; and for those &gt;25 mm, 40 percent. Another prospective cohort study followed 374 patients with 448 aneurysms that were &lt;5 mm in size; the average annual rupture rate was 0.54 percent overall, 0.34 percent for single aneurysms, and 0.95 percent for multiple aneurysms [<a href="#rid70">70</a>]. In this group, aneurysm rupture risk was also somewhat higher in those &lt;50 years of age and those with aneurysms &gt;4 mm in size. Hazard ratios reported in the UCAS, using aneurysms 3 to 4 mm as the reference, were 3.3 for aneurysms 7 to 9 mm, 9.1 for aneurysms 10 to 24 mm, and 76.3 for aneurysms ≥25 mm [<a href="#rid67">67</a>].</p><p>Aneurysm growth is more likely to occur in larger than smaller aneurysm [<a href="#rid71">71,72</a>]. Among 165 patients with 191 unruptured aneurysms, the frequency of enlargement over 47 months was 7, 25, and 83 percent for aneurysms &lt;8 mm, 8 to 12 mm, and &gt;13 mm, respectively [<a href="#rid72">72</a>]. One study also found that internal carotid and basilar artery aneurysms were more likely to grow than those located in other regions [<a href="#rid71">71</a>].</p><p>The results of one study suggest that risks of rupture in smaller, &lt;5 mm aneurysms can be further stratified by the aneurysm-to-vessel size ratio; a ratio of 3.1 was the threshold identified for a higher risk of rupture (odds ratio 9.10) [<a href="#rid73">73,74</a>]. This finding requires independent verification. </p><p class="headingAnchor" id="H429083399"><span class="h2">Aneurysm growth</span><span class="headingEndMark"> — </span>Based in part upon the theory of aneurysm growth and rupture discussed above as well as the data that associated aneurysm size and risk of rupture, it is believed that aneurysms that grow in size are also at high risk of rupture and that untreated aneurysms should be monitored for growth. (See <a class="local">'Monitoring'</a> below.)</p><p>The data supporting this are expectedly somewhat limited. One study followed 165 patients with 258 unruptured aneurysms with serial computed tomography angiography (CTA) [<a href="#rid75">75</a>]. Eighteen percent of aneurysms were observed to grow larger and were associated with a higher rate of rupture than those that did not grow (2.4 versus 0.2 percent per year).</p><p class="headingAnchor" id="H16"><span class="h2">Site</span><span class="headingEndMark"> — </span>Both the ISUIA and the UCAS, as well as other studies, have found that the risk of aneurysm rupture varied according to its location [<a href="#rid54">54,67,76</a>].</p><p>In the ISUIA, three aneurysm site groupings were associated with different rates of rupture [<a href="#rid54">54</a>]. The three groupings of aneurysm site were based on the parent artery:</p><p class="bulletIndent1"><span class="glyph">●</span>Cavernous carotid artery aneurysms had the lowest rates of rupture.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anterior circulation aneurysms, involving the anterior communicating, anterior cerebral, or internal carotid arteries, had intermediate rates of rupture.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Posterior circulation aneurysms, involving the vertebrobasilar, posterior cerebral arterial system, or posterior communicating arteries, had the highest rates of rupture.</p><p></p><p>The cumulative five-year rate of rupture according to aneurysm site and size at diagnosis were as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>For 7 to 12 mm aneurysms, rupture rates for cavernous carotid, anterior circulation, and posterior circulation aneurysms were 0, 2.6, and 14.5 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For 13 to 24 mm aneurysms, rupture rates for cavernous carotid, anterior circulation, and posterior circulation aneurysms were 3.0, 14.5, and 18.4 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For 25 mm or larger aneurysms, rupture rates for cavernous carotid, anterior circulation, and posterior circulation aneurysms were 6.4, 40, and 50 percent.</p><p></p><p>In the UCAS, aneurysms in the anterior and posterior communicating arteries were more likely to rupture than those in the middle cerebral artery [<a href="#rid67">67</a>]. Using the latter group as a reference, the hazard ratios associated with rupture in the posterior and anterior communicating arteries were 1.9 and 2.0, respectively.</p><p class="headingAnchor" id="H17"><span class="h2">Racial differences</span><span class="headingEndMark"> — </span>It is unclear whether racial or genetic background has a substantial impact upon the natural history of unruptured intracranial aneurysms. The prospective ISUIA data were obtained primarily from white populations in North America and Europe, but no similar large prospective study has been published in other populations. However, predisposition to aneurysm formation is clearly influenced by genetic makeup (see <a class="local">'Genetic factors'</a> above), and there is epidemiologic evidence of wide variations in the rate of SAH worldwide [<a href="#rid77">77</a>].</p><p>Although not directly comparable, data from a systematic review of 13 retrospective studies of unruptured intracranial aneurysms in Japan [<a href="#rid78">78</a>] found a much higher overall rupture rate than that reported in the ISUIA study [<a href="#rid54">54</a>]. Similar to the ISUIA data, the risk of rupture in Japan was significantly increased for large, posterior circulation and symptomatic aneurysms [<a href="#rid78">78</a>]. Most of the studies in the Japanese review included a mix of patients with and without prior SAH, populations that appear to have different risks in the prospective ISUIA study. Prospective studies underway in Japan may address these issues [<a href="#rid79">79,80</a>].</p><p class="headingAnchor" id="H796072314"><span class="h2">Precipitating events</span><span class="headingEndMark"> — </span>An acute trigger event such as physical exertion appears to occur in some cases of aneurysm rupture but not all. Emotionally stressful life events have not been convincingly shown to be a trigger for aneurysm rupture. (See  <a class="medical medical_review" href="/d/html/90075.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Epidemiology, risk factors, and pathogenesis", section on 'Pathogenesis'</a>.)</p><p class="headingAnchor" id="H18"><span class="h2">Prior hemorrhage</span><span class="headingEndMark"> — </span>If an individual has had a previous aneurysmal SAH, the risk of rupture of a separate aneurysm is probably higher than if the individual did not have that history. In the ISUIA, unruptured aneurysms less than 7 mm in a patient with a history of aneurysmal SAH ruptured at a rate of 0.5 percent per year compared with 0.1 percent per year in those with no prior aneurysmal SAH [<a href="#rid54">54</a>]. A higher risk for those with prior SAH was not noted for larger aneurysm categories in the ISUIA, but the number of patients with large unruptured aneurysms and prior SAH was relatively small.</p><p class="headingAnchor" id="H19"><span class="h2">Family history</span><span class="headingEndMark"> — </span>Familial aneurysms tend to rupture at a smaller size and younger age than sporadic aneurysms [<a href="#rid17">17,27,28</a>]. In one study, the observed rupture rate of 1.2 percent per year was almost 17 times higher than the rupture rate of aneurysms matched for size and location in the ISUIA [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H1387175269"><span class="h2">Others</span><span class="headingEndMark"> — </span>In the UCAS, the presence of a daughter sac (an irregular protrusion of the aneurysm wall) was associated with an increased risk of rupture (hazard ratio = 1.6), while the presence of thrombus or calcification did not appear to influence the risk of rupture [<a href="#rid67">67</a>]. One study found that multiple aneurysms were more likely to grow than single lesions [<a href="#rid76">76</a>]. Studies of advanced imaging techniques hold the promise that new technologies will be able to identify other characteristics of aneurysms at high risk of rupture, such as inflammation within the aneurysm wall [<a href="#rid81">81</a>].</p><p>In both the ISUIA and UCAS, the effect of patient's age, gender, hypertension, and tobacco smoking were not significant predictors of SAH in a multivariate analysis [<a href="#rid54">54,67</a>]. By contrast, a case-control study comparing patients with ruptured and unruptured cerebral aneurysm found that smoking and a migraine history appeared to increase the risk of rupture, while hypercholesterolemia (or possibly its treatment with statins) appeared to be protective [<a href="#rid82">82</a>]. In this study, the prevalence of hypertension, age, and gender was not different between the groups. Other prospective follow-up studies in patients with unruptured aneurysms have found that aneurysm rupture was associated with cigarette smoking and younger patient age [<a href="#rid75">75,83</a>]. </p><p class="headingAnchor" id="H22"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>The management of unruptured intracranial aneurysms is controversial [<a href="#rid84">84</a>]. There are no randomized trials on which to base recommendations. Decisions about therapy need to weigh the natural history of the aneurysm, the risks of intervention, and patient preferences.</p><p class="headingAnchor" id="H23"><span class="h2">Risk of intervention</span><span class="headingEndMark"> — </span>A systematic review and meta-analysis of the available observational studies included 60 studies, 9845 patients, and 10,845 aneurysms. The overall mortality associated with surgical clipping of unruptured aneurysms was 1.7 percent; unfavorable outcomes occurred in 6.7 percent [<a href="#rid85">85</a>]. </p><p>Observational studies that compared the risks of surgical versus endovascular repair in general found lower rates of poor outcomes in patients treated with endovascular repair. In the International Study of Unruptured Intracranial Aneurysms (ISUIA), rates of poor neurologic outcome at one year were 12.6 and 9.8 percent for those treated surgically and endovascularly, respectively [<a href="#rid54">54</a>]. In another cohort study, endovascular repair was associated with lower mortality (0.6 versus 1.6 percent) and lower rates of stroke (4.3 versus 9.0 percent) [<a href="#rid86">86</a>]. </p><p>Risk factors for poor outcomes include advanced age, larger aneurysm size, and location in the posterior circulation; these are more consistently observed in surgically rather than endovascularly treated patients [<a href="#rid54">54,87</a>].</p><p>Age is a crucial element in deciding whether to treat an unruptured aneurysm [<a href="#rid44">44</a>]. Morbidity and mortality are increased with open surgery in patients 50 years and older and with endovascular procedures in patients 70 years and older. However, age has relatively little effect on the natural history of unruptured aneurysms.</p><p class="headingAnchor" id="H24"><span class="h2">Benefit of intervention</span><span class="headingEndMark"> — </span>The ISUIA investigators concluded that in patients without a history of previous subarachnoid hemorrhage (SAH), it is unlikely that any therapy would be able to improve upon the untreated natural history of aneurysms that are smaller than 7 mm, and they also suggested that in patients with larger asymptomatic unruptured aneurysms, patient preference for immediate risk versus risk over time might determine the appropriate course of action.</p><p>The investigators also point to specific groups from their data that appear to have the largest benefit from intervention, such as open surgery for patients younger than 50 years with aneurysms of the posterior communicating artery that are 7 to 24 mm. Although it may be appropriate to take these subgroup data into account when making recommendations for individual patients, it is important to recognize that such subgroup analyses are vulnerable to statistical problems and need to be confirmed prospectively.</p><p>The management of unruptured intracranial aneurysms has also been evaluated by studies performing cost-effectiveness analyses. One such study, published prior to the prospective 2003 ISUIA report [<a href="#rid54">54</a>], found that treatment of asymptomatic aneurysms &lt;10 mm in diameter in patients with no history of SAH from another aneurysm worsened clinical outcomes; treatment of unruptured aneurysms that were larger, symptomatic, or in patients with a history of SAH was cost effective [<a href="#rid88">88</a>]. Aneurysm location was not considered in this analysis.</p><p>A later decision and cost-effectiveness analysis used the 2003 ISUIA data and compared surgical or endovascular treatment with no treatment for unruptured intracranial aneurysms [<a href="#rid89">89</a>]. The following observations were reported:</p><p class="bulletIndent1"><span class="glyph">●</span>For 50-year-old patients, treatment was ineffective or not cost effective for aneurysms with the following characteristics:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Small (&lt;7 mm), due to the low risk of rupture</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Located in the cavernous carotid artery</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Large (&gt;25 mm) and located in the posterior circulation, due to the high risk of complications from treatment</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For 40-year-old patients, treatment was ineffective or not cost effective for aneurysms with the following characteristics:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Small (&lt;12 mm) or large (&gt;25 mm) and located in the cavernous carotid artery</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Small (&lt;7 mm) and located in the anterior circulation</p><p></p><p class="headingAnchor" id="H30"><span class="h2">Indications for intervention</span><span class="headingEndMark"> — </span>The available studies emphasize the need to examine each case individually, considering factors such as comorbid medical illness, patient age, aneurysm size and location, and risks of treatment. The sum of these data supports expectant management of very small saccular aneurysms, particularly when such aneurysms are located in the anterior circulation or when they are detected in older patients.</p><p>A task force of the Stroke Council of the American Heart Association published recommendations (also prior to the 2003 ISUIA data) for the management of patients with an unruptured intracranial aneurysm that are similar to the above recommendations [<a href="#rid90">90</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The treatment of small incidental intracavernous internal carotid artery aneurysms is generally not indicated. For large symptomatic intracavernous aneurysms, treatment decisions should be individualized on the basis of patient age, severity and progression of symptoms, and treatment alternatives. The higher risk of treatment and shorter life expectancy in older individuals must be considered in all patients, and it favors observation in older patients with asymptomatic aneurysms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Symptomatic intradural aneurysms of all sizes should be considered for treatment with relative urgency.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Coexisting or remaining aneurysms of all sizes in patients with an SAH due to another treated aneurysm warrant consideration for treatment. Aneurysms located at the basilar apex carry a relatively high risk of rupture. Treatment decisions must take into account the patient's age, existing medical and neurologic condition, and relative risks of repair. If a decision is made for observation, reevaluation on a periodic basis with computed tomography angiography (CTA)/magnetic resonance angiography (MRA) or selective contrast angiography should be considered, with changes in aneurysmal size sought, although careful attention to technical factors will be required to optimize the reliability of these measures.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Given the apparent low risk of hemorrhage from incidental, small (&lt;7 mm) aneurysms in patients without previous SAH, observation rather than intervention is generally advocated. However, special consideration for treatment should be given to young (&lt;50 years) patients in this group.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Asymptomatic aneurysms ≥7 to 10 mm in diameter warrant strong consideration for treatment, taking into account patient age, existing medical and neurologic conditions, and relative risks for treatment [<a href="#rid91">91</a>].</p><p></p><p class="headingAnchor" id="H48585018"><span class="h2">Choice of procedure</span><span class="headingEndMark"> — </span>Surgical treatment of unruptured aneurysms has been the most common procedure used in patients who undergo definitive therapy. In clinical studies, which are typically in centers with high case volumes, endovascular techniques appear to be associated with lower morbidity and mortality than surgical clipping and are playing an increasing role in the treatment of unruptured aneurysms [<a href="#rid92">92-96</a>]. (See  <a class="medical medical_review" href="/d/html/90190.html" rel="external">"Treatment of cerebral aneurysms", section on 'Patients with unruptured aneurysms'</a>.)</p><p>New technologies, such as flow diversion, may advance the safety of endovascular treatment and allow aneurysms, previously considered to be inaccessible or technologically difficult for such treatment, to undergo treatment [<a href="#rid97">97</a>].</p><p class="headingAnchor" id="H115807930"><span class="h2">Special situations</span></p><p class="headingAnchor" id="H2068684013"><span class="h3">With AVM</span><span class="headingEndMark"> — </span>Rare patients have an intracranial aneurysm associated with an intracranial arteriovenous malformation (AVM). These aneurysms are more likely to be associated with growth and rupture than aneurysms in general [<a href="#rid98">98</a>]. Therefore, repairing the aneurysm prior to treating the AVM is recommended.</p><p class="headingAnchor" id="H3565123816"><span class="h3">Carotid stenosis</span><span class="headingEndMark"> — </span>One study found that intracranial aneurysms appeared to be more common than expected in a population of patients with symptomatic carotid artery disease, perhaps because of shared risk factors [<a href="#rid99">99</a>]. Aneurysms distal to a symptomatic cervical internal carotid artery stenosis may be susceptible to sudden hemodynamic changes with carotid endarterectomy (CEA) that could lead to aneurysmal rupture [<a href="#rid44">44</a>]. On the other hand, surgical clipping of an aneurysm distal to a severe internal carotid stenosis may increase the risk of ischemic stroke.</p><p>Unfortunately, data for this situation are too sparse to allow firm conclusions as to which problem should be tackled first. However, caution is advised if CEA is performed in this setting, especially if the unruptured ipsilateral aneurysm is 7 mm or larger in diameter or if there is a history of SAH from another aneurysm.</p><p class="headingAnchor" id="H4131561367"><span class="h3">Use of antithrombotic therapy</span><span class="headingEndMark"> — </span>Patients with intracranial aneurysms may require antithrombotic therapy for the management of other conditions such as atrial fibrillation. The available data are limited, somewhat conflicting, and not sufficient to determine whether anticoagulant (eg, <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a>) or antiplatelet therapy increases the risk of aneurysm rupture. [<a href="#rid100">100</a>]. Anticoagulant therapy does appear to increase the severity of rupture should it occur.</p><p>The available data regarding the risks of antithrombotic therapy in patients with unruptured aneurysm are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/1320.html" rel="external">"Anticoagulant and antiplatelet therapy in patients with an unruptured intracranial aneurysm"</a>.)</p><p class="headingAnchor" id="H31"><span class="h2">Monitoring</span><span class="headingEndMark"> — </span>For patients with unruptured intracranial aneurysms that are not treated with open surgery or endovascular methods, the following recommendations are made for monitoring [<a href="#rid44">44</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>We suggest that unruptured intracranial aneurysms be monitored with CTA or MRA annually for two to three years, and every two to five years thereafter if the aneurysm is clinically and radiographically stable [<a href="#rid44">44</a>]. However, it is not unreasonable to obtain the first reimaging study of newly detected small aneurysms at six months, since there is evidence that newly formed small aneurysms may be at higher risk of rupture than older, more stable aneurysms (see <a class="local">'Aneurysm growth and rupture'</a> above). Longer reimaging intervals are certainly appropriate if the six-month study shows no significant change.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients should be instructed to avoid smoking, heavy alcohol consumption, stimulant medications, illicit drugs, and excessive straining and Valsalva maneuvers.</p><p></p><p>Patients whose aneurysm is treated are at risk for recurrent aneurysm formation and require monitoring. This is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/16257.html" rel="external">"Late recurrence of subarachnoid hemorrhage and intracranial aneurysms"</a>.)</p><p class="headingAnchor" id="H14163013"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/16264.html" rel="external">"Patient education: Brain aneurysm (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H796341115"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>In the general population, the prevalence of unruptured intracranial aneurysms is estimated to be approximately 3 percent. A higher risk of intracranial aneurysm formation occurs in certain genetic syndromes including Ehlers-Danlos syndrome, polycystic kidney disease (PKD), and others. Apart from these genetic syndromes, a family history of intracranial aneurysm is also a risk factor. Nongenetic risk factors include hypertension and cigarette smoking.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most unruptured aneurysms present as an incidental finding on a neuroimaging study or in screening. Occasionally, aneurysms can produce compressive symptoms such as a third cranial nerve palsy. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Magnetic resonance angiography (MRA) and computed tomography angiography (CTA) appear to be able to detect aneurysms 5 mm or larger. Conventional angiography is more sensitive, but carries procedural risks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The most common treatments for aneurysms are surgical clipping and endovascular coiling.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Indications for intervention take into account the risk of aneurysm rupture. In general, we suggest treatment of most nonintracavernous intracranial aneurysms that are greater than 7 to 10 mm in size, while observation and monitoring is suggested for smaller aneurysms. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with an intracranial aneurysm should be monitored for aneurysm growth, aneurysm recurrence, and new aneurysm formation.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Etminan N, Rinkel GJ. Unruptured intracranial aneurysms: development, rupture and preventive management. Nat Rev Neurol 2016; 12:699.</a></li><li><a class="nounderline abstract_t">Brown RD Jr, Broderick JP. Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol 2014; 13:393.</a></li><li><a class="nounderline abstract_t">Rinkel GJE. Management of patients with unruptured intracranial aneurysms. Curr Opin Neurol 2019; 32:49.</a></li><li><a class="nounderline abstract_t">Hackenberg KAM, Hänggi D, Etminan N. Unruptured Intracranial Aneurysms. Stroke 2018; 49:2268.</a></li><li><a class="nounderline abstract_t">Ellis JA, Nossek E, Kronenburg A, et al. Intracranial Aneurysm: Diagnostic Monitoring, Current Interventional Practices, and Advances. Curr Treat Options Cardiovasc Med 2018; 20:94.</a></li><li><a class="nounderline abstract_t">Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007; 357:1821.</a></li><li><a class="nounderline abstract_t">Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 2011; 10:626.</a></li><li><a class="nounderline abstract_t">STEHBENS WE. ANEURYSMS AND ANATOMICAL VARIATION OF CEREBRAL ARTERIES. Arch Pathol 1963; 75:45.</a></li><li><a class="nounderline abstract_t">Sarti C, Tuomilehto J, Salomaa V, et al. Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke 1991; 22:848.</a></li><li><a class="nounderline abstract_t">Schievink WI. Intracranial aneurysms. N Engl J Med 1997; 336:28.</a></li><li><a class="nounderline abstract_t">Alg VS, Sofat R, Houlden H, Werring DJ. Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals. Neurology 2013; 80:2154.</a></li><li><a class="nounderline abstract_t">Neil-Dwyer G, Bartlett JR, Nicholls AC, et al. Collagen deficiency and ruptured cerebral aneurysms. A clinical and biochemical study. J Neurosurg 1983; 59:16.</a></li><li><a class="nounderline abstract_t">Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000; 342:673.</a></li><li><a class="nounderline abstract_t">Conway JE, Hutchins GM, Tamargo RJ. Marfan syndrome is not associated with intracranial aneurysms. Stroke 1999; 30:1632.</a></li><li><a class="nounderline abstract_t">Litchfield WR, Anderson BF, Weiss RJ, et al. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 1998; 31:445.</a></li><li><a class="nounderline abstract_t">Chalhoub V, Abi-Rafeh L, Hachem K, et al. Intracranial aneurysm and recessive polycystic kidney disease: the third reported case. JAMA Neurol 2013; 70:114.</a></li><li><a class="nounderline abstract_t">Ronkainen A, Hernesniemi J, Puranen M, et al. Familial intracranial aneurysms. Lancet 1997; 349:380.</a></li><li><a class="nounderline abstract_t">Raaymakers TW. Aneurysms in relatives of patients with subarachnoid hemorrhage: frequency and risk factors. MARS Study Group. Magnetic Resonance Angiography in Relatives of patients with Subarachnoid hemorrhage. Neurology 1999; 53:982.</a></li><li><a class="nounderline abstract_t">Bromberg JE, Rinkel GJ, Algra A, et al. Familial subarachnoid hemorrhage: distinctive features and patterns of inheritance. Ann Neurol 1995; 38:929.</a></li><li><a class="nounderline abstract_t">Wills S, Ronkainen A, van der Voet M, et al. Familial intracranial aneurysms: an analysis of 346 multiplex Finnish families. Stroke 2003; 34:1370.</a></li><li><a class="nounderline abstract_t">Onda H, Kasuya H, Yoneyama T, et al. Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet 2001; 69:804.</a></li><li><a class="nounderline abstract_t">Hashikata H, Liu W, Inoue K, et al. Confirmation of an association of single-nucleotide polymorphism rs1333040 on 9p21 with familial and sporadic intracranial aneurysms in Japanese patients. Stroke 2010; 41:1138.</a></li><li><a class="nounderline abstract_t">van der Voet M, Olson JM, Kuivaniemi H, et al. Intracranial aneurysms in Finnish families: confirmation of linkage and refinement of the interval to chromosome 19q13.3. Am J Hum Genet 2004; 74:564.</a></li><li><a class="nounderline abstract_t">Deka R, Koller DL, Lai D, et al. The relationship between smoking and replicated sequence variants on chromosomes 8 and 9 with familial intracranial aneurysm. Stroke 2010; 41:1132.</a></li><li><a class="nounderline abstract_t">Foroud T, Koller DL, Lai D, et al. Genome-wide association study of intracranial aneurysms confirms role of Anril and SOX17 in disease risk. Stroke 2012; 43:2846.</a></li><li><a class="nounderline abstract_t">Hussain I, Duffis EJ, Gandhi CD, Prestigiacomo CJ. Genome-wide association studies of intracranial aneurysms: an update. Stroke 2013; 44:2670.</a></li><li><a class="nounderline abstract_t">St Jean P, Hart B, Webster M, et al. Alpha-1-antitrypsin deficiency in aneurysmal disease. Hum Hered 1996; 46:92.</a></li><li><a class="nounderline abstract_t">Broderick JP, Brown RD Jr, Sauerbeck L, et al. Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms. Stroke 2009; 40:1952.</a></li><li><a class="nounderline abstract_t">Mackey J, Brown RD Jr, Moomaw CJ, et al. Familial intracranial aneurysms: is anatomic vulnerability heritable? Stroke 2013; 44:38.</a></li><li><a class="nounderline abstract_t">Teunissen LL, Rinkel GJ, Algra A, van Gijn J. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke 1996; 27:544.</a></li><li><a class="nounderline abstract_t">Knekt P, Reunanen A, Aho K, et al. Risk factors for subarachnoid hemorrhage in a longitudinal population study. J Clin Epidemiol 1991; 44:933.</a></li><li><a class="nounderline abstract_t">Leppälä JM, Paunio M, Virtamo J, et al. Alcohol consumption and stroke incidence in male smokers. Circulation 1999; 100:1209.</a></li><li><a class="nounderline abstract_t">Vlak MH, Rinkel GJ, Greebe P, Algra A. Independent risk factors for intracranial aneurysms and their joint effect: a case-control study. Stroke 2013; 44:984.</a></li><li><a class="nounderline abstract_t">Bonita R. Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study. Stroke 1986; 17:831.</a></li><li><a class="nounderline abstract_t">Stober T, Sen S, Anstätt T, et al. Direct evidence of hypertension and the possible role of post-menopause oestrogen deficiency in the pathogenesis of berry aneurysms. J Neurol 1985; 232:67.</a></li><li><a class="nounderline abstract_t">Taylor CL, Yuan Z, Selman WR, et al. Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: hypertension and other risk factors. J Neurosurg 1995; 83:812.</a></li><li><a class="nounderline abstract_t">Longstreth WT, Nelson LM, Koepsell TD, van Belle G. Subarachnoid hemorrhage and hormonal factors in women. A population-based case-control study. Ann Intern Med 1994; 121:168.</a></li><li><a class="nounderline abstract_t">Mhurchu CN, Anderson C, Jamrozik K, et al. Hormonal factors and risk of aneurysmal subarachnoid hemorrhage: an international population-based, case-control study. Stroke 2001; 32:606.</a></li><li class="breakAll">Perloff JK. The Clinical Recognition of Congenital Heart Disease, 4th ed, WB Saunders, Philadelphia 1994.</li><li><a class="nounderline abstract_t">HODES HL, STEINFELD L, BLUMENTHAL S. Congenital cerebral aneurysms and coarctation of the aorta. Arch Pediatr 1959; 76:28.</a></li><li><a class="nounderline abstract_t">Connolly HM, Huston J 3rd, Brown RD Jr, et al. Intracranial aneurysms in patients with coarctation of the aorta: a prospective magnetic resonance angiographic study of 100 patients. Mayo Clin Proc 2003; 78:1491.</a></li><li><a class="nounderline abstract_t">Austin G, Fisher S, Dickson D, et al. The significance of the extracellular matrix in intracranial aneurysms. Ann Clin Lab Sci 1993; 23:97.</a></li><li><a class="nounderline abstract_t">Patel RL, Richards P, Chambers DJ, Venn G. Infective endocarditis complicated by ruptured cerebral mycotic aneurysm. J R Soc Med 1991; 84:746.</a></li><li><a class="nounderline abstract_t">Wiebers DO, Piepgras DG, Meyer FB, et al. Pathogenesis, natural history, and treatment of unruptured intracranial aneurysms. Mayo Clin Proc 2004; 79:1572.</a></li><li><a class="nounderline abstract_t">Starke RM, Chalouhi N, Ali MS, et al. The role of oxidative stress in cerebral aneurysm formation and rupture. Curr Neurovasc Res 2013; 10:247.</a></li><li><a class="nounderline abstract_t">Chalouhi N, Ali MS, Starke RM, et al. Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture. Mediators Inflamm 2012; 2012:271582.</a></li><li><a class="nounderline abstract_t">Aoki T, Nishimura M. Targeting chronic inflammation in cerebral aneurysms: focusing on NF-kappaB as a putative target of medical therapy. Expert Opin Ther Targets 2010; 14:265.</a></li><li><a class="nounderline abstract_t">Chalouhi N, Points L, Pierce GL, et al. Localized increase of chemokines in the lumen of human cerebral aneurysms. Stroke 2013; 44:2594.</a></li><li><a class="nounderline abstract_t">Frösen J, Piippo A, Paetau A, et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke 2004; 35:2287.</a></li><li><a class="nounderline abstract_t">Pyysalo MJ, Pyysalo LM, Pessi T, et al. The connection between ruptured cerebral aneurysms and odontogenic bacteria. J Neurol Neurosurg Psychiatry 2013; 84:1214.</a></li><li><a class="nounderline abstract_t">Hallikainen J, Keränen S, Savolainen J, et al. Role of oral pathogens in the pathogenesis of intracranial aneurysm: review of existing evidence and potential mechanisms. Neurosurg Rev 2021; 44:239.</a></li><li><a class="nounderline abstract_t">Wiebers DO, Whisnant JP, Sundt TM Jr, O'Fallon WM. The significance of unruptured intracranial saccular aneurysms. J Neurosurg 1987; 66:23.</a></li><li><a class="nounderline abstract_t">Sato K, Yoshimoto Y. Risk profile of intracranial aneurysms: rupture rate is not constant after formation. Stroke 2011; 42:3376.</a></li><li><a class="nounderline abstract_t">Wiebers DO, Whisnant JP, Huston J 3rd, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003; 362:103.</a></li><li><a class="nounderline abstract_t">International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms--risk of rupture and risks of surgical intervention. N Engl J Med 1998; 339:1725.</a></li><li><a class="nounderline abstract_t">Wiebers DO, Whisnant JP, O'Fallon WM. The natural history of unruptured intracranial aneurysms. N Engl J Med 1981; 304:696.</a></li><li><a class="nounderline abstract_t">Forget TR Jr, Benitez R, Veznedaroglu E, et al. A review of size and location of ruptured intracranial aneurysms. Neurosurgery 2001; 49:1322.</a></li><li><a class="nounderline abstract_t">White PM, Wardlaw J. Unruptured intracranial aneurysms: prospective data have arrived. Lancet 2003; 362:90.</a></li><li><a class="nounderline abstract_t">Raps EC, Rogers JD, Galetta SL, et al. The clinical spectrum of unruptured intracranial aneurysms. Arch Neurol 1993; 50:265.</a></li><li><a class="nounderline abstract_t">Friedman JA, Piepgras DG, Pichelmann MA, et al. Small cerebral aneurysms presenting with symptoms other than rupture. Neurology 2001; 57:1212.</a></li><li><a class="nounderline abstract_t">Huston J 3rd, Nichols DA, Luetmer PH, et al. Blinded prospective evaluation of sensitivity of MR angiography to known intracranial aneurysms: importance of aneurysm size. AJNR Am J Neuroradiol 1994; 15:1607.</a></li><li><a class="nounderline abstract_t">Schwartz RB, Tice HM, Hooten SM, et al. Evaluation of cerebral aneurysms with helical CT: correlation with conventional angiography and MR angiography. Radiology 1994; 192:717.</a></li><li><a class="nounderline abstract_t">White PM, Teadsale E, Wardlaw JM, Easton V. What is the most sensitive non-invasive imaging strategy for the diagnosis of intracranial aneurysms? J Neurol Neurosurg Psychiatry 2001; 71:322.</a></li><li><a class="nounderline abstract_t">van Gelder JM. Computed tomographic angiography for detecting cerebral aneurysms: implications of aneurysm size distribution for the sensitivity, specificity, and likelihood ratios. Neurosurgery 2003; 53:597.</a></li><li><a class="nounderline abstract_t">Menke J, Larsen J, Kallenberg K. Diagnosing cerebral aneurysms by computed tomographic angiography: meta-analysis. Ann Neurol 2011; 69:646.</a></li><li><a class="nounderline abstract_t">Li MH, Li YD, Tan HQ, et al. Contrast-free MRA at 3.0 T for the detection of intracranial aneurysms. Neurology 2011; 77:667.</a></li><li><a class="nounderline abstract_t">UCAS Japan Investigators, Morita A, Kirino T, et al. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012; 366:2474.</a></li><li><a class="nounderline abstract_t">Greving JP, Wermer MJ, Brown RD Jr, et al. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol 2014; 13:59.</a></li><li><a class="nounderline abstract_t">Rabinstein AA. Intracranial aneurysms: individualising the risk of rupture. Lancet Neurol 2014; 13:25.</a></li><li><a class="nounderline abstract_t">Sonobe M, Yamazaki T, Yonekura M, Kikuchi H. Small unruptured intracranial aneurysm verification study: SUAVe study, Japan. Stroke 2010; 41:1969.</a></li><li><a class="nounderline abstract_t">Matsubara S, Hadeishi H, Suzuki A, et al. Incidence and risk factors for the growth of unruptured cerebral aneurysms: observation using serial computerized tomography angiography. J Neurosurg 2004; 101:908.</a></li><li><a class="nounderline abstract_t">Burns JD, Huston J 3rd, Layton KF, et al. Intracranial aneurysm enlargement on serial magnetic resonance angiography: frequency and risk factors. Stroke 2009; 40:406.</a></li><li><a class="nounderline abstract_t">Kashiwazaki D, Kuroda S, Sapporo SAH Study Group. Size ratio can highly predict rupture risk in intracranial small (&lt;5 mm) aneurysms. Stroke 2013; 44:2169.</a></li><li><a class="nounderline abstract_t">Mocco J, Brown RD Jr, Torner JC, et al. Aneurysm Morphology and Prediction of Rupture: An International Study of Unruptured Intracranial Aneurysms Analysis. Neurosurgery 2018; 82:491.</a></li><li><a class="nounderline abstract_t">Villablanca JP, Duckwiler GR, Jahan R, et al. Natural history of asymptomatic unruptured cerebral aneurysms evaluated at CT angiography: growth and rupture incidence and correlation with epidemiologic risk factors. Radiology 2013; 269:258.</a></li><li><a class="nounderline abstract_t">Chien A, Liang F, Sayre J, et al. Enlargement of small, asymptomatic, unruptured intracranial aneurysms in patients with no history of subarachnoid hemorrhage: the different factors related to the growth of single and multiple aneurysms. J Neurosurg 2013; 119:190.</a></li><li><a class="nounderline abstract_t">Ingall T, Asplund K, Mähönen M, Bonita R. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 2000; 31:1054.</a></li><li><a class="nounderline abstract_t">Morita A, Fujiwara S, Hashi K, et al. Risk of rupture associated with intact cerebral aneurysms in the Japanese population: a systematic review of the literature from Japan. J Neurosurg 2005; 102:601.</a></li><li><a class="nounderline abstract_t">Morita A. [On-line outcome study of unruptured cerebral aneurysm in Japan (UCAS Japan)]. Rinsho Shinkeigaku 2002; 42:1188.</a></li><li><a class="nounderline abstract_t">Yonekura M. Small unruptured aneurysm verification (SUAVe Study, Japan)--interim report. Neurol Med Chir (Tokyo) 2004; 44:213.</a></li><li><a class="nounderline abstract_t">Hasan D, Chalouhi N, Jabbour P, et al. Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study. Stroke 2012; 43:3258.</a></li><li><a class="nounderline abstract_t">Vlak MH, Rinkel GJ, Greebe P, Algra A. Risk of rupture of an intracranial aneurysm based on patient characteristics: a case-control study. Stroke 2013; 44:1256.</a></li><li><a class="nounderline abstract_t">Juvela S, Poussa K, Lehto H, Porras M. Natural history of unruptured intracranial aneurysms: a long-term follow-up study. Stroke 2013; 44:2414.</a></li><li><a class="nounderline abstract_t">Johnston SC, Wilson CB, Halbach VV, et al. Endovascular and surgical treatment of unruptured cerebral aneurysms: comparison of risks. Ann Neurol 2000; 48:11.</a></li><li><a class="nounderline abstract_t">Kotowski M, Naggara O, Darsaut TE, et al. Safety and occlusion rates of surgical treatment of unruptured intracranial aneurysms: a systematic review and meta-analysis of the literature from 1990 to 2011. J Neurol Neurosurg Psychiatry 2013; 84:42.</a></li><li><a class="nounderline abstract_t">Alshekhlee A, Mehta S, Edgell RC, et al. Hospital mortality and complications of electively clipped or coiled unruptured intracranial aneurysm. Stroke 2010; 41:1471.</a></li><li><a class="nounderline abstract_t">Ogilvy CS, Carter BS. Stratification of outcome for surgically treated unruptured intracranial aneurysms. Neurosurgery 2003; 52:82.</a></li><li><a class="nounderline abstract_t">Johnston SC, Gress DR, Kahn JG. Which unruptured cerebral aneurysms should be treated? A cost-utility analysis. Neurology 1999; 52:1806.</a></li><li><a class="nounderline abstract_t">Takao H, Nojo T. Treatment of unruptured intracranial aneurysms: decision and cost-effectiveness analysis. Radiology 2007; 244:755.</a></li><li><a class="nounderline abstract_t">Bederson JB, Awad IA, Wiebers DO, et al. Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2000; 102:2300.</a></li><li><a class="nounderline abstract_t">Greving JP, Rinkel GJ, Buskens E, Algra A. Cost-effectiveness of preventive treatment of intracranial aneurysms: new data and uncertainties. Neurology 2009; 73:258.</a></li><li><a class="nounderline abstract_t">Johnston SC, Zhao S, Dudley RA, et al. Treatment of unruptured cerebral aneurysms in California. Stroke 2001; 32:597.</a></li><li><a class="nounderline abstract_t">Vallee JN, Aymard A, Vicaut E, et al. Endovascular treatment of basilar tip aneurysms with Guglielmi detachable coils: predictors of immediate and long-term results with multivariate analysis 6-year experience. Radiology 2003; 226:867.</a></li><li><a class="nounderline abstract_t">Raftopoulos C, Goffette P, Vaz G, et al. Surgical clipping may lead to better results than coil embolization: results from a series of 101 consecutive unruptured intracranial aneurysms. Neurosurgery 2003; 52:1280.</a></li><li><a class="nounderline abstract_t">Zacharia BE, Ducruet AF, Hickman ZL, et al. Technological advances in the management of unruptured intracranial aneurysms fail to improve outcome in New York state. Stroke 2011; 42:2844.</a></li><li><a class="nounderline abstract_t">McDonald JS, McDonald RJ, Fan J, et al. Comparative effectiveness of unruptured cerebral aneurysm therapies: propensity score analysis of clipping versus coiling. Stroke 2013; 44:988.</a></li><li><a class="nounderline abstract_t">De Vries J, Boogaarts J, Van Norden A, Wakhloo AK. New generation of Flow Diverter (surpass) for unruptured intracranial aneurysms: a prospective single-center study in 37 patients. Stroke 2013; 44:1567.</a></li><li><a class="nounderline abstract_t">Wiebers DO, Torres VE. Screening for unruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 1992; 327:953.</a></li><li><a class="nounderline abstract_t">Héman LM, Jongen LM, van der Worp HB, et al. Incidental intracranial aneurysms in patients with internal carotid artery stenosis: a CT angiography study and a metaanalysis. Stroke 2009; 40:1341.</a></li><li><a class="nounderline abstract_t">Hasan DM, Mahaney KB, Brown RD Jr, et al. Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 2011; 42:3156.</a></li></ol></div><div id="topicVersionRevision">Topic 1132 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27808265" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Unruptured intracranial aneurysms: development, rupture and preventive management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24646873" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30516639" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Management of patients with unruptured intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30355003" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Unruptured Intracranial Aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30353282" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Intracranial Aneurysm: Diagnostic Monitoring, Current Interventional Practices, and Advances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17978290" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Incidental findings on brain MRI in the general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21641282" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14087271" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : ANEURYSMS AND ANATOMICAL VARIATION OF CEREBRAL ARTERIES.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1853404" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8970938" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23733552" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6864273" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Collagen deficiency and ruptured cerebral aneurysms. A clinical and biochemical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10706896" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10436113" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Marfan syndrome is not associated with intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9453343" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23318517" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Intracranial aneurysm and recessive polycystic kidney disease: the third reported case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9033463" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Familial intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10496256" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Aneurysms in relatives of patients with subarachnoid hemorrhage: frequency and risk factors. MARS Study Group. Magnetic Resonance Angiography in Relatives of patients with Subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8526466" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Familial subarachnoid hemorrhage: distinctive features and patterns of inheritance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12750547" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Familial intracranial aneurysms: an analysis of 346 multiplex Finnish families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11536080" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20395613" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Confirmation of an association of single-nucleotide polymorphism rs1333040 on 9p21 with familial and sporadic intracranial aneurysms in Japanese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14872410" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Intracranial aneurysms in Finnish families: confirmation of linkage and refinement of the interval to chromosome 19q13.3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20190001" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The relationship between smoking and replicated sequence variants on chromosomes 8 and 9 with familial intracranial aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22961961" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Genome-wide association study of intracranial aneurysms confirms role of Anril and SOX17 in disease risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23908070" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Genome-wide association studies of intracranial aneurysms: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8666418" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Alpha-1-antitrypsin deficiency in aneurysmal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19228834" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23204049" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Familial intracranial aneurysms: is anatomic vulnerability heritable?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8610327" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Risk factors for subarachnoid hemorrhage: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1890435" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Risk factors for subarachnoid hemorrhage in a longitudinal population study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10484542" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Alcohol consumption and stroke incidence in male smokers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23422088" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Independent risk factors for intracranial aneurysms and their joint effect: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3094199" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3160833" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Direct evidence of hypertension and the possible role of post-menopause oestrogen deficiency in the pathogenesis of berry aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7472548" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: hypertension and other risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8017743" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Subarachnoid hemorrhage and hormonal factors in women. A population-based case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11239175" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Hormonal factors and risk of aneurysmal subarachnoid hemorrhage: an international population-based, case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11239175" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Hormonal factors and risk of aneurysmal subarachnoid hemorrhage: an international population-based, case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13618092" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Congenital cerebral aneurysms and coarctation of the aorta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14661678" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Intracranial aneurysms in patients with coarctation of the aorta: a prospective magnetic resonance angiographic study of 100 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7681275" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The significance of the extracellular matrix in intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1774755" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Infective endocarditis complicated by ruptured cerebral mycotic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15595346" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Pathogenesis, natural history, and treatment of unruptured intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23713738" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The role of oxidative stress in cerebral aneurysm formation and rupture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23316103" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20128708" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Targeting chronic inflammation in cerebral aneurysms: focusing on NF-kappaB as a putative target of medical therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23887838" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Localized increase of chemokines in the lumen of human cerebral aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15322297" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23761916" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The connection between ruptured cerebral aneurysms and odontogenic bacteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32034564" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Role of oral pathogens in the pathogenesis of intracranial aneurysm: review of existing evidence and potential mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3783255" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The significance of unruptured intracranial saccular aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21980206" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Risk profile of intracranial aneurysms: rupture rate is not constant after formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12867109" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9867550" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Unruptured intracranial aneurysms--risk of rupture and risks of surgical intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7464862" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The natural history of unruptured intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11846931" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A review of size and location of ruptured intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12867103" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Unruptured intracranial aneurysms: prospective data have arrived.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8442705" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The clinical spectrum of unruptured intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11591837" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Small cerebral aneurysms presenting with symptoms other than rupture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7857409" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Blinded prospective evaluation of sensitivity of MR angiography to known intracranial aneurysms: importance of aneurysm size.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8058939" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Evaluation of cerebral aneurysms with helical CT: correlation with conventional angiography and MR angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11511704" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : What is the most sensitive non-invasive imaging strategy for the diagnosis of intracranial aneurysms?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12943576" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Computed tomographic angiography for detecting cerebral aneurysms: implications of aneurysm size distribution for the sensitivity, specificity, and likelihood ratios.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21391230" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Diagnosing cerebral aneurysms by computed tomographic angiography: meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21775735" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Contrast-free MRA at 3.0 T for the detection of intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22738097" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The natural course of unruptured cerebral aneurysms in a Japanese cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24290159" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24290160" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Intracranial aneurysms: individualising the risk of rupture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20671254" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Small unruptured intracranial aneurysm verification study: SUAVe study, Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15597749" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Incidence and risk factors for the growth of unruptured cerebral aneurysms: observation using serial computerized tomography angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19023101" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Intracranial aneurysm enlargement on serial magnetic resonance angiography: frequency and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23743979" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Size ratio can highly predict rupture risk in intracranial small (&lt;5 mm) aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28605486" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Aneurysm Morphology and Prediction of Rupture: An International Study of Unruptured Intracranial Aneurysms Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23821755" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Natural history of asymptomatic unruptured cerebral aneurysms evaluated at CT angiography: growth and rupture incidence and correlation with epidemiologic risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23621603" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Enlargement of small, asymptomatic, unruptured intracranial aneurysms in patients with no history of subarachnoid hemorrhage: the different factors related to the growth of single and multiple aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10797165" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15871500" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Risk of rupture associated with intact cerebral aneurysms in the Japanese population: a systematic review of the literature from Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12784702" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : [On-line outcome study of unruptured cerebral aneurysm in Japan (UCAS Japan)].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15185763" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Small unruptured aneurysm verification (SUAVe Study, Japan)--interim report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23138441" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23520239" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Risk of rupture of an intracranial aneurysm based on patient characteristics: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23868274" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Natural history of unruptured intracranial aneurysms: a long-term follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10894211" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Endovascular and surgical treatment of unruptured cerebral aneurysms: comparison of risks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23012447" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Safety and occlusion rates of surgical treatment of unruptured intracranial aneurysms: a systematic review and meta-analysis of the literature from 1990 to 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20522817" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Hospital mortality and complications of electively clipped or coiled unruptured intracranial aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12493104" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Stratification of outcome for surgically treated unruptured intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10371527" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Which unruptured cerebral aneurysms should be treated? A cost-utility analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17652191" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Treatment of unruptured intracranial aneurysms: decision and cost-effectiveness analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11056108" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council of the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19299311" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Cost-effectiveness of preventive treatment of intracranial aneurysms: new data and uncertainties.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11239174" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Treatment of unruptured cerebral aneurysms in California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12601216" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Endovascular treatment of basilar tip aneurysms with Guglielmi detachable coils: predictors of immediate and long-term results with multivariate analysis 6-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12762873" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Surgical clipping may lead to better results than coil embolization: results from a series of 101 consecutive unruptured intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21852601" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Technological advances in the management of unruptured intracranial aneurysms fail to improve outcome in New York state.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23449260" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Comparative effectiveness of unruptured cerebral aneurysm therapies: propensity score analysis of clipping versus coiling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23686973" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : New generation of Flow Diverter (surpass) for unruptured intracranial aneurysms: a prospective single-center study in 37 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1513354" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Screening for unruptured intracranial aneurysms in autosomal dominant polycystic kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19228836" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Incidental intracranial aneurysms in patients with internal carotid artery stenosis: a CT angiography study and a metaanalysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21980208" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
